1 / 6

External Defibrillators Market Is Expected to See Extensive Worldwide Growth By 2023

Global External Defibrillators Market was valued at $4,345 million in 2016 and is expected to garner $7,512 million by 2023, registering a CAGR of 7.8% during the forecast period 2017 - 2023.

newmarketindustry
Download Presentation

External Defibrillators Market Is Expected to See Extensive Worldwide Growth By 2023

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. External Defibrillators Market

  2. The recommendation for the usage of automated external defibrillators at public places has rapidly increased the adoption rate in the developed economies. Moreover, the rationalizing use of wearable cardioverter defibrillator (WCDs), accepted as temporary alternative or bridge to long-term ICD implantation is going to drive the market for external defibrillators. External Defibrillators Market was valued at $4,345 million in 2016 and is expected to garner $7,512 million by 2023, registering a CAGR of 7.8% during the forecast period 2017 - 2023. Automated External defibrillators (AEDs) segment accounted for more than five-sevenths share of the global market in 2016. Get Sample Report

  3. External defibrillators are devices used to deliver therapeutic shock to a patients heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The major factors that boost the market growth include technological advancements such as advent of automated external defibrillators (AEDs) for public access places, rise in incidence of sudden cardiac arrest, and growth in awareness toward public access defibrillators worldwide. Moreover, improving healthcare attractiveness is anticipated to boost the sale of home care defibrillators such as wearable external defibrillators and automated external defibrillator (AEDs).

  4. The ability of the defibrillator device to diagnose early onset of ventricular tachycardia and ventricular defibrillation is expected to promote their demand. Nevertheless, cost-effectiveness, safety, high accessibility, and clinical value in preliminary treatment of sudden cardiac arrest strengthen the technological advancements in the defibrillators market. However, lack of awareness toward the availability of external defibrillator to prevent sudden cardiac arrest (SCA) and safety concerns related to automated external defibrillators are projected to hamper the market growth.

  5. Key Findings of External Defibrillators Market: • In 2016, automated external defibrillators (AEDs) led the overall external defibrillator market revenue, and is projected to grow at a CAGR of 7.8% during the forecast period. • The AEDs segment occupied the highest share in 2016, and is expected to grow at a CAGR of 12.8%, in terms of volume. • North America was the leading consumer of external defibrillators in 2016, both in terms of value and volume, followed by Europe. • Japan is expected to lead market in the Asia-Pacific region in 2016, growing at a CAGR 8.9% from 2017-2023.

  6. Wearable cardioverter defibrillator (WCDs) is poised to grow at the fastest rate during the forecast period owing to the non-invasive nature and increased demand of home healthcare for the treatment of sudden cardiac arrest. Wearable external defibrillator segment is expected to grow at a remarkable CAGR of 11.3% from 2017-2023. Key players operating in the market include Nihon Kohden Corporation, Cardiac Science Corporation, Philips Healthcare, HeartSine Technologies LLC., ZOLL Medical Corporation, Mindray Medical International Limited, Defibtech, Llc, Physio-Control, Inc., GE Healthcare, and Schiller Ag.

More Related